Completed PHASE4 INTERVENTIONAL 1-arm NCT00517426

Effects of Acetazolamide and CO2 Inhalation on Exercise-induced Periodic Breathing in Heart Failure

Sponsor: Centro Cardiologico Monzino

Updated 6 times since 2017 Last updated: Jan 27, 2016 Started: Jul 31, 2007 Primary completion: Jul 31, 2011 Completion: Aug 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Chronic Heart Failure, this trial is completed. The trial is conducted by Centro Cardiologico Monzino and has accumulated 6 data snapshots since 2007. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Feb 2017 — Jun 2018 [monthly]

Completed PHASE4

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed PHASE4

First recorded

Jul 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Centro Cardiologico Monzino

Data source: Centro Cardiologico Monzino

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Milan, Italy